27
Overview of the current situation for H1N1 Influenza in Australia & Internationally MISMS Oceania Influenza Meeting MELBOURNE - 16 March 2010 Professor Jim Bishop AO Chief Medical Officer

Overview of the current situation for H1N1 Influenza in Australia & Internationally

Embed Size (px)

DESCRIPTION

A presentation by Australia's Chief Medical Officer, Professor Jim Bishop AO, to the MISMS Oceania Influenza Meeting. 16 March 2010

Citation preview

Page 1: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Overview of the current situation for H1N1 Influenza in

Australia amp Internationally

MISMS Oceania Influenza Meeting

MELBOURNE -

16 March 2010

Professor Jim Bishop AO Chief Medical Officer

The Australian Health Management Plan for Pandemic Influenza (AHMPPI)

bull

The AHMPPI (2008) third edition of the national health management plan

bull

Revised as a result of Exercise Cumpston 06ndash

Addressing policy gaps

ndash

Streamlined decision makingndash

More flexible policy

Australian Health Protection Committee (AHPC) Aileen Plant National Incident Room

bull

The key decision-making body for health emergenciesndash

Chaired by DoHA Deputy Secretary

ndash

Commonwealth CMO ST Chief Health Officers

ndash

Experts in mental health emergency medicine communicable diseases

bull

Preparedness role

bull

Response role in health emergencies

4

WHO announces health emergency24 Apr

WHO moves to Pandemic phase 427 Apr

Australia moves to

Pandemic DELAY28 Apr

WHO moves to Pandemic

phase 529 Apr

Australia moves to Pandemic

CONTAIN22 May

Victoria moves to MODIFIED

SUSTAIN3 Jun

WHO moves to Pandemic

phase 611 Jun

Australia moves to Pandemic

PROTECT17 Jun

TGA Approves pandemic (H1N1) vaccine WHO Donation18 Sept

30 Sept Adult Vaccination Program commences

TGA Approves and registers pandemic vaccine

for children5 Dec

PANDEMIC (H1N1) 2009 TIMELINE

DELAY PHASE

CONTAIN PHASE

bull

Contact tracing and home quarantinebull

Anti-virals for contacts

bull

Increased public messaging bull

Some school closures

bull

Continuation of the measures commenced in DELAY

Actions taken during CONTAIN included

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 2: Overview of the current situation for H1N1 Influenza in Australia & Internationally

The Australian Health Management Plan for Pandemic Influenza (AHMPPI)

bull

The AHMPPI (2008) third edition of the national health management plan

bull

Revised as a result of Exercise Cumpston 06ndash

Addressing policy gaps

ndash

Streamlined decision makingndash

More flexible policy

Australian Health Protection Committee (AHPC) Aileen Plant National Incident Room

bull

The key decision-making body for health emergenciesndash

Chaired by DoHA Deputy Secretary

ndash

Commonwealth CMO ST Chief Health Officers

ndash

Experts in mental health emergency medicine communicable diseases

bull

Preparedness role

bull

Response role in health emergencies

4

WHO announces health emergency24 Apr

WHO moves to Pandemic phase 427 Apr

Australia moves to

Pandemic DELAY28 Apr

WHO moves to Pandemic

phase 529 Apr

Australia moves to Pandemic

CONTAIN22 May

Victoria moves to MODIFIED

SUSTAIN3 Jun

WHO moves to Pandemic

phase 611 Jun

Australia moves to Pandemic

PROTECT17 Jun

TGA Approves pandemic (H1N1) vaccine WHO Donation18 Sept

30 Sept Adult Vaccination Program commences

TGA Approves and registers pandemic vaccine

for children5 Dec

PANDEMIC (H1N1) 2009 TIMELINE

DELAY PHASE

CONTAIN PHASE

bull

Contact tracing and home quarantinebull

Anti-virals for contacts

bull

Increased public messaging bull

Some school closures

bull

Continuation of the measures commenced in DELAY

Actions taken during CONTAIN included

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 3: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Australian Health Protection Committee (AHPC) Aileen Plant National Incident Room

bull

The key decision-making body for health emergenciesndash

Chaired by DoHA Deputy Secretary

ndash

Commonwealth CMO ST Chief Health Officers

ndash

Experts in mental health emergency medicine communicable diseases

bull

Preparedness role

bull

Response role in health emergencies

4

WHO announces health emergency24 Apr

WHO moves to Pandemic phase 427 Apr

Australia moves to

Pandemic DELAY28 Apr

WHO moves to Pandemic

phase 529 Apr

Australia moves to Pandemic

CONTAIN22 May

Victoria moves to MODIFIED

SUSTAIN3 Jun

WHO moves to Pandemic

phase 611 Jun

Australia moves to Pandemic

PROTECT17 Jun

TGA Approves pandemic (H1N1) vaccine WHO Donation18 Sept

30 Sept Adult Vaccination Program commences

TGA Approves and registers pandemic vaccine

for children5 Dec

PANDEMIC (H1N1) 2009 TIMELINE

DELAY PHASE

CONTAIN PHASE

bull

Contact tracing and home quarantinebull

Anti-virals for contacts

bull

Increased public messaging bull

Some school closures

bull

Continuation of the measures commenced in DELAY

Actions taken during CONTAIN included

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 4: Overview of the current situation for H1N1 Influenza in Australia & Internationally

4

WHO announces health emergency24 Apr

WHO moves to Pandemic phase 427 Apr

Australia moves to

Pandemic DELAY28 Apr

WHO moves to Pandemic

phase 529 Apr

Australia moves to Pandemic

CONTAIN22 May

Victoria moves to MODIFIED

SUSTAIN3 Jun

WHO moves to Pandemic

phase 611 Jun

Australia moves to Pandemic

PROTECT17 Jun

TGA Approves pandemic (H1N1) vaccine WHO Donation18 Sept

30 Sept Adult Vaccination Program commences

TGA Approves and registers pandemic vaccine

for children5 Dec

PANDEMIC (H1N1) 2009 TIMELINE

DELAY PHASE

CONTAIN PHASE

bull

Contact tracing and home quarantinebull

Anti-virals for contacts

bull

Increased public messaging bull

Some school closures

bull

Continuation of the measures commenced in DELAY

Actions taken during CONTAIN included

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 5: Overview of the current situation for H1N1 Influenza in Australia & Internationally

DELAY PHASE

CONTAIN PHASE

bull

Contact tracing and home quarantinebull

Anti-virals for contacts

bull

Increased public messaging bull

Some school closures

bull

Continuation of the measures commenced in DELAY

Actions taken during CONTAIN included

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 6: Overview of the current situation for H1N1 Influenza in Australia & Internationally

CONTAIN PHASE

bull

Contact tracing and home quarantinebull

Anti-virals for contacts

bull

Increased public messaging bull

Some school closures

bull

Continuation of the measures commenced in DELAY

Actions taken during CONTAIN included

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 7: Overview of the current situation for H1N1 Influenza in Australia & Internationally

H1N1 Influenza 09 Pandemic Phases

ALERT (pre 24 April 09)

DELAY (24 April 09)

CONTAIN (22 May 09)

SUSTAIN

Victoria moved to a MODIFIED SUSTAIN on 3 June 2009

CONTROL

RECOVER

PROTECT

17 June 2009

Evidence supports focusing efforts on protecting the lsquovulnerablersquo

Australias response is continual informed by the emerging evidence around the virus and effectiveness of control measures

H1N1 Influenza 09 mild in most and severe in

some (the vulnerable)

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 8: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Key Elements of PROTECT

bull Re-focus of testing and treatmentbull Identification and early treatment for those at risk bull

Voluntary home isolation no treatment mild disease

bull Controlling outbreaks in special settingsbull Limited school closures early in the Pandemicbull Communicationsbull Re-focus surveillance

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 9: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Office of Health Protection Surveillance Branch Department of Health and Ageing

PANDEMIC (H1N1) 2009 SURVEILLANCE AUSTRALIA

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 10: Overview of the current situation for H1N1 Influenza in Australia & Internationally

0

200

400

600

800

1000

1200

1400

1600

805

200

9

220

520

09

506

200

9

190

620

09

307

200

9

170

720

09

310

720

09

140

820

09

280

820

09

110

920

09

250

920

09

910

200

9

231

020

09

611

200

9

201

120

09

412

200

9

181

220

09

101

201

0

150

120

10

290

120

10

120

220

10

260

220

10

Date of onset notification

Num

ber o

f con

firm

ed c

ases

of p

ande

mic

(H1N

1) 2

009

ACT NSW NT Qld

SA Tas Vic WA

VIC moved to modified SUSTAIN phase

AUS phase PROTECT

Vaccination commenced

Source NetEPI database

Source NetEPI

database

Laboratory Confirmed CasesOf Pandemic (H1N1) in Australia

to 26 February 2010

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 11: Overview of the current situation for H1N1 Influenza in Australia & Internationally

0

10

20

30

40

50

60

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53Week

Rat

e of

ILI p

er 1

000

con

sulta

tions

ASPREN 2007ASPREN 2008ASPREN + NT + VIDRL 2009ASPREN + NT 2010

First case of Pandemic

(H1N1) 2009 reported in Australia

bullDelays in the reporting of data may cause data to change retrospectively As data from the NT surveillance system is combined with ASPREN data for 2010 rates may not be directly comparable across 2007 2008 and 2009 SOURCE ASPREN and NT GP surveillance system

Sentinel General Practice Surveillance1 January 2007 to 21 February 2010

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 12: Overview of the current situation for H1N1 Influenza in Australia & Internationally

0

200

400

600

800

1000

1200

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51Week

Num

ber o

f Em

erge

ncy

Dep

artm

ent I

LI

Pre

sent

atio

ns in

WA

2007 Presentations2008 Presentations2009 Presentations2010 Presentations

Child deaths associated with

influenza infection in 2007

Source WA lsquoVirus Watchrsquo Report

WA Emergency Departments1 January 2007 to 14 February 2010

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 13: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Source NSW lsquoInfluenza Monthly Epidemiology Reportrsquo

Deaths Associated with Influenza and Pneumonia 2005 - 2010

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 14: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Rates of absenteeism (greater than 3 days absent) national employerfrom 28 January 2007 to 17 February 2010 by week

0

02

04

06

08

1

12

14

16

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53

Week

Per

cent

of S

taff

Abs

ent

2007 Absenteeism2008 Absenteeism2009 Absenteeism2010 Absenteeism

SOURCE Absenteeism data

ABSENTEEISM28 Jan 2007 to 17 Feb 2010

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 15: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Overview of pandemic (H1N1) 2009 severity ndash to 26 February 2010

2009 2010Pandemic (H1N1) 2009 Confirmed

casesHospitalised

casesICU cases Deaths Confirmed

casesHospitalised

casesICU

casesDeaths

Total number 37636 13 ofConfirmed

cases

14 ofHospitalised

cases

191 44 +186

InfluenzaType A

11 1 0

Crude rate per100000 population

1721 228 31 09 02

Median age (years) 21 31 44 53 30

Females 51 51 53 44 29

Vulnerable groups na 58 74 67

Indigenous people 11 20 19 13

Pregnant women na 27 Hospitalisedfemales aged15-44 years

16 Hospitalised

Pregnantwomen

4

Cases with at least 1co-morbidity

na 46 67 62

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 16: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Severe Pandemic (H1N1) 2009

Hospitalisations-

Respiratory diabetes immuno compromised obesity chronic cardiac renal pregnancy rapid deteriorating flu patient

Higher proportion of Indigenous Australians

Over 50 admitted within 48 hours of onset

Higher ICU Admissions than expected

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 17: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Hospitalisations of pandemic (H1N1) 2009 5 June ndash

23 October 2009 by week

17

0

100

200

300

400

500

600

700

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43

Week of report

Num

ber o

f hos

pita

lista

tions

ass

ocia

ted

with

pan

dem

ic (H

1N1)

200

9

Australia

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 18: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of

hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia

18

00

100

200

300

400

500

600

700

800

0-4

5-9

10-1

415

-19

20-2

425

-29

30-3

435

-39

40-4

445

-49

50-5

455

-59

60-6

465

-69

70-7

475

-79

80-8

485

+

Age group (5 Years)

Age

spec

ific

rate

(per

100

000

pop

ulat

ion) Males pandemic (H1N1) 2009

Females pandemic (H1N1) 2009

2004-07 seasonal influenza

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 19: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009

0

200

400

600

800

1000

1200

1400

0-9 10-19 20-29 30-39 40-49 50-59 60+

Age groups (10 years)

Tota

l num

ber

of h

ospi

talis

atio

ns

and

ICU

adm

issi

ons

of

conf

irmed

cas

es

0

10

20

30

40

50

60

Num

bers

of d

eath

s of

con

firm

ed

case

s

HospICUDeaths

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 20: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Notification rates for pandemic (H1N1) 2009 in a selection of affected countries

Country Population Confirmed cases Crude rate per 100000

population

Hospitalisation rate per 100000 population

Deaths Trends

Southern Hemisphere

Australia 21262641 37636 1721 228 191 Low influenza activity

New Zealand 4319932 3233 730 227 18 Low levels of ILI decreasing trend

Argentina 40482000 11234 278 337 613 Low ILI activity decreasing trend

Chile 16454143 12276 746 98 150 Low ILI activity decreasing trend

Northern Hemisphere

Canada 33212696 NA 235 44 336 Low influenza activity

UK 60943912 26110 428 NA 265 Decreasing influenza activity

Mexico 109955400 66070 601 na 671 na

USA 304059724 50768 165 103 1336 Low influenza activity

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 21: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Pandemic (H1N1) 2009 Vaccine

bull

Safety profile as with seasonal flu

bull

One injection 15μg protects adults

bull

FDA licenceTGA registration

bull

Emphasis on priority groups but available to ALL

Source New England Journal of Medicine 2009 361 September 10

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 22: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Clinical Trials of Pandemic (H1N1) 2009 Vaccine

Systemic Side effects

Headache

Fever

Myalgia

Malaise

Immune Response15mcg

97

30mcg 93

Source New England Journal of Medicine 2009 361 September 10

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 23: Overview of the current situation for H1N1 Influenza in Australia & Internationally

VACCINE ROLL OUT

bull

Around 76 million doses distributed (35

population)

bull

Available for this Influenza season

bull

Trivalent vaccine for seasonal influenza available

to targeted groups

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 24: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Key lessons so far

1

Value of detailed planning2

Leadership and co-ordination

bull

AHPCbull

NPEC

3

Flexibility4

Medical innovation

5

Communication

NEJM on line publication ndash

Dec 2009

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 25: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Current Situation ndash

2010

bull

Influenza activity low in Australia but showing some signs of increasing earlier than usualndash

lt2 respiratory tests positive for influenza

ndash

55 confirmed cases influenza per week

bull

Pandemic strain predominant in Australiandash

35 pandemic (H1N1) 2009

bull

Pandemic (H1N1) 2009 predominant in most countries

bull

Type B predominant in China (83) and Hong Kong (56)

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 26: Overview of the current situation for H1N1 Influenza in Australia & Internationally

Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type

0

10

20

30

40

50

60

2012010 9012010 16012010 23012010 30012010 6022010 13022010 20022010

Week of onsetnotification - start date

Num

ber o

f con

firm

ed in

fluen

za c

ases

AMexico2232009(H1N1) AH1N1 strain unknownA not subtyped AH1N1Brisbane592007AH3N2 AH3n2Brisbane102007 BUntyped AampB

Current Situation -

2010

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE
Page 27: Overview of the current situation for H1N1 Influenza in Australia & Internationally

KEY INDIVIDUALS FOR PANDEMIC RESPONSE

NIRMs Mary MurnaneMs Jenny BryantDr Gary LumMs Fay GardnerDr Bernie TowlerDr Andrew SingerDr Andrea FordeMs Kay McNieceDr Jenean Spencer

Prof Terry Nolan ATAGIDr Chris Mitchell RACGPDr Vicki Krause CDNA

NSW

Dr Kerry Chant

Dr Jeremy McAnulty

VIC

Dr John Carnie

Dr Rosemary Lester

QLD

Dr Jeanette Young

Dr Christine Selvey

TAS

Dr Chrissie Pickin

WA

Dr Tarun Weeramanthri

Dr Andy Robertson

SA

Dr Stephen Christley

ACT

Dr Charles Guest

NT

Dr Barbara Paterson

  • Overview of the current situation for H1N1 Influenza in Australia amp Internationally
  • Slide Number 2
  • Slide Number 3
  • Slide Number 4
  • Slide Number 5
  • Slide Number 6
  • Slide Number 7
  • Slide Number 8
  • Slide Number 9
  • Slide Number 10
  • Slide Number 11
  • Slide Number 12
  • Slide Number 13
  • Slide Number 14
  • Slide Number 15
  • Severe Pandemic (H1N1) 2009
  • Hospitalisations of pandemic (H1N1) 2009 5 June ndash 23 October 2009 by week
  • Age specific rates of hospitalised confirmed cases of pandemic (H1N1) 2009 to 3 October 2009 compared with average annual age specific rates of hospitalisations from seasonal influenza 2004-05 to 2006-07 Australia
  • Comparison of hospitalisations ICU admissions and deaths by age group to 2 October 2009
  • Notification rates for pandemic (H1N1) 2009 in a selection of affected countries
  • Pandemic (H1N1) 2009 Vaccine
  • Clinical Trials of Pandemic (H1N1) 2009 Vaccine
  • VACCINE ROLL OUT
  • Key lessons so far
  • Current Situation ndash 2010
  • Laboratory confirmed cases of influenza (pandemic (H1N1) 2009 and seasonal) in Australia 2010 to 26 February by week and type
  • KEY INDIVIDUALS FOR PANDEMIC RESPONSE